MedPath

Elucidation of new molecular mechanism of pancreatic cancer development by subgingival plaque microbiome analysis

Not Applicable
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000052739
Lead Sponsor
Shimane University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

1) All molars are missing 2) (Pancreatic tumor group) Patients with malignant tumors other than the pancreas. 3) (Disease control group) (Control group) Has a history of pancreatic resection. 4) (Disease control group) (Control group) Abdominal MRI or abdominal contrast-enhanced CT indicates pancreatic tumor, chronic pancreatitis, or pancreatic cystic lesion.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composition of bacterial flora
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath